Moe Alsumidaie is Chief Editor of The Clinical Trial Vanguard. Moe holds decades of experience in the clinical trials industry.
Moe also serves as Head of Research at CliniBiz and Chief Data Scientist at Annex Clinical Corporation.
Tenaya Therapeutics announced interim data from its RIDGE natural history study of adults with arrhythmogenic right ventricular cardiomyopathy (ARVC)...
Mineralys Therapeutics announced positive Phase 2 Advance-HTN trial results for lorundrostat, a novel treatment for uncontrolled or resistant hypertension...